Randomized trial or adjuvant tamoxifen pour years vs two years in node positive breast cancer women.

被引：0
|
作者：
Gallén, M [1 ]
Alonso, C [1 ]
Ojeda, B [1 ]
Viladíu, P [1 ]
Beltrán, W [1 ]
Borrás, J [1 ]
Tusquets, I [1 ]
Arcusa, A [1 ]
Barnadas, A [1 ]
Bastús, R [1 ]
Balil, A [1 ]
Batiste-Alentorn, E [1 ]
Guasch, I [1 ]
Garau, I [1 ]
Boleda, W [1 ]
Badia, A [1 ]
机构：
[1] Hosp Del Mar, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [1] Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer
    Gallen, M
    Alonso, C
    Ojeda, B
    Viladiu, P
    Beltran, M
    Borras, J
    Pelegri, A
    Tusquets, I
    Barnadas, A
    Arcusa, A
    Bastus, R
    Balil, A
    Batiste-Alentorn, E
    Boleda, M
    Badia, MA
    Garau, I
    Guash, I
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S40 - S40
  • [2] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    Machin, D
    Andersen, KW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 659 - 659
  • [3] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    Rutqvist, LE
    Hatschek, T
    Ryden, S
    Bergh, J
    Bengtsson, NO
    Carstenssen, J
    Nordenskjold, B
    Wallgren, A
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) : 1543 - 1549
  • [4] A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE BREAST-CANCER
    DEMBO, AJ
    PRITCHARD, KI
    MEAKIN, JW
    BOYD, NF
    AMBUS, U
    EVANS, WK
    SUTHERLAND, DJA
    WILKINSON, RH
    BASSETT, A
    CAMPBELL, J
    DEBOER, G
    PATERSON, AHG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (02): : 118 - 118
  • [5] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer - Response
    Rutqvist, LE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) : 659 - 660
  • [6] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    Coombes, RC
    Hall, E
    Gibson, LJ
    Paridaens, R
    Jassem, J
    Delozier, T
    Jones, SE
    Alvarez, I
    Bertelli, G
    Ortmann, O
    Coates, AS
    Bajetta, E
    Dodwell, D
    Coleman, RE
    Fallowfield, LJ
    Mickiewicz, E
    Andersen, J
    Lonning, PE
    Cocconi, G
    Stewart, A
    Stuart, N
    Snowdon, CF
    Carpentieri, M
    Massimini, G
    Bliss, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11): : 1081 - 1092
  • [7] RANDOMIZED TRIAL OF ADJUVANT TAMOXIFEN IN NODE NEGATIVE POSTMENOPAUSAL BREAST-CANCER
    RUTQVIST, LE
    CEDERMARK, B
    GLAS, U
    JOHANSSON, H
    ROTSTEIN, S
    SKOOG, L
    SOMELL, A
    THEVE, T
    WILKING, N
    ASKERGREN, J
    HJALMAR, ML
    RINGBORG, U
    ACTA ONCOLOGICA, 1992, 31 (02) : 265 - 270
  • [8] Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer
    Tormey, DC
    Gray, R
    Falkson, HC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24): : 1828 - 1833
  • [9] Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group for Cancer Evaluation study of adjuvant treatment in breast cancer 01
    Sacco, M
    Valentini, M
    Belfiglio, M
    Pellegrini, F
    De Berardis, G
    Franciosi, M
    Nicolucci, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2276 - 2281
  • [10] Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer
    Silliman, RA
    Guadagnoli, E
    Rakowski, W
    Landrum, MB
    Lash, TL
    Wolf, R
    Fink, A
    Ganz, PA
    Gurwitz, J
    Borbas, C
    Mor, V
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2680 - 2688
12345